Prospective evaluation of novel 22G FNA needle for pancreatic lesions
Not Applicable
- Conditions
- Pancreatic tumors
- Registration Number
- JPRN-UMIN000025708
- Lead Sponsor
- Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication of EUS-FNA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of 22G FNA needles in pancreatic tumor diagnosis?
How does the 22G FNA needle compare to standard 25G needles in pancreatic lesion biopsy success rates?
Are there specific biomarkers that correlate with improved diagnostic yield using 22G FNA needles in pancreatic cancer?
What are the potential adverse events associated with 22G FNA needle use in pancreatic tumor sampling?
What are the current trends in fine needle aspiration technology for pancreatic cancer diagnosis and how does this trial contribute?